Is the FDA Too Cautious?
Open to Debate
The FDA's Precautionary Approach to Drug Approval
Peter Lorry: FDA at this point is more or less gotten at right, and you'll hear some criticisms from me. But when we talk about caution, let's at least unpack the question. Are we talking about caution as in too fast or not fast enough? And I would submit that FDA is not too cautious with respect to either of these.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
